RxDoctor Payments Data

Philip Keller

Physician Assistant · Nags Head, NCNPI 1649505082

Payments from drug & device makers

$556in general payments, 2019–2025

Across 30 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$211
  • Alkermes, Inc.$83
  • Sunovion Pharmaceuticals Inc.$71
  • Otsuka America Pharmaceutical, Inc.$71
  • Supernus Pharmaceuticals, Inc.$37
  • Eisai Inc.$32
  • plus $53 from 3 others

What the payments were for

  • Food & beverage$556100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$556 in reported general payments places this provider in the 60th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$31,385
Medicare patients
136
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate43$132,258
RexultiBrexpiprazole62$104,906
CaplytaLumateperone Tosylate16$25,733
AristadaAripiprazole Lauroxil13$19,312
Chlorpromazine Hcl27$14,697
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl78$12,924
Lurasidone Hcl47$12,164
Risperdal ConstaRisperidone Microspheres20$11,617
VyvanseLisdexamfetamine Dimesylate24$9,847
Clozapine96$9,302
CymbaltaDuloxetine Hcl16$6,502
Aripiprazole235$5,643
Haloperidol145$5,236
Olanzapine261$5,026
Ziprasidone Hcl134$4,857

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$71$104,90662 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$211$25,73316 claims
Alkermes, Inc.Aristada$83$19,31213 claims
Teva Pharmaceuticals USA, Inc.Loxapine$14$1,08919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Nags Head

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →